We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Exploratory Investigation of a Male Focused Skincare Supplement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05319847
Recruitment Status : Completed
First Posted : April 8, 2022
Last Update Posted : September 26, 2022
Sponsor:
Collaborator:
Citruslabs
Information provided by (Responsible Party):
Let's Disco

Brief Summary:
Most skincare products on the market are topical and do not take a holistic approach to understanding skin health. This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective. Research has previously supported the link between the gut microbiome and skin health and the supplement tested in this trial will further the knowledge on the effectiveness of supporting gut health to improve skin outcomes.

Condition or disease Intervention/treatment Phase
Acne Skin Abnormalities Dietary Supplement: Daily Skin Supplement - Fountain of Youth Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 38 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Masking Description: Open Label, Single Group Design
Primary Purpose: Treatment
Official Title: An Exploratory Investigation of a Male Focused Skincare Supplement
Actual Study Start Date : April 15, 2022
Actual Primary Completion Date : June 30, 2022
Actual Study Completion Date : June 30, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention arm
Daily Skin Supplement - Fountain of Youth
Dietary Supplement: Daily Skin Supplement - Fountain of Youth
Skincare supplement




Primary Outcome Measures :
  1. Adult Acne [ Time Frame: 12 week ]
    Change in overall frequency and intensity of adult acne (Likert Scale 0-5 with higher scores representing a reduction in the appearance of adult acne)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male
  • Between the ages of 18-55
  • Frequently experience different forms of acne
  • Frequently experience breakouts
  • Must be in good health with no long term health conditions
  • BMI must be under 40
  • Must follow a consistent dietary regimen
  • Must be willing to stop any oral supplementation targeting their skin while in the trail

Exclusion Criteria:

  • Anyone who does take prescription medication (oral or topical) targeting their skin including reinoid, over the counter retinol, or retinal
  • Not willing to stop any oral supplementation targeting their skin
  • Severe chronic conditions, including oncological and psychiatric disorders
  • Previous severe allergic reactions
  • Unwilling the follow the study protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05319847


Locations
Layout table for location information
United States, California
Citruslabs
Santa Monica, California, United States, 90404
Sponsors and Collaborators
Let's Disco
Citruslabs
Layout table for additonal information
Responsible Party: Let's Disco
ClinicalTrials.gov Identifier: NCT05319847    
Other Study ID Numbers: 20239Disco
First Posted: April 8, 2022    Key Record Dates
Last Update Posted: September 26, 2022
Last Verified: September 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Skin Abnormalities
Congenital Abnormalities
Skin Diseases